Serán Bioscience
Bend, OR
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (8)
○ EMA GMP
○ MHRA GMP
Quick Facts: Serán Bioscience
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Bend, OR
- Modalities
- Small Molecule (Oral Solid Dose), Spray Dried Dispersion (SDD), Hot Melt Extrusion (HME), Nano-milling / Nanoparticulate, Fluid Bed Processing, Particle Engineering, Pulmonary / Inhaled Particulates, Nasal Drug Delivery, Finished Dose (tablets, capsules, OPCs, powder-in-bottle)
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Serán Bioscience
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSmall Molecule (Oral Solid Dose), Spray Dried Dispersion (SDD), Hot Melt Extrusion (HME), Nano-milling / Nanoparticulate, Fluid Bed Processing, Particle Engineering, Pulmonary / Inhaled Particulates, Nasal Drug Delivery, Finished Dose (tablets, capsules, OPCs, powder-in-bottle)
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (9 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press8 articles
Broad modality coverage (9 modalities)
Recent News 8 articles
The Evolving Landscape: Cutting-Edge Approaches for Difficult-to-Deliver Molecules - Contract Pharma
Serán Bioscience Announces $200 Million Strategic Growth Transaction and Plans for New Commercial Facility - Bain Capital
CDMO Serán snags $200M Bain-led investment to build its first commercial facility - Fierce Pharma
Serán Bioscience Expands Commercial Manufacturing in Bend, OR - Contract Pharma
Ropes & Gray Represents Bain Capital in Strategic Growth Investment in Serán Bioscience - Ropes & Gray LLP
Serán Bioscience: $200 Million Strategic Growth Transaction Raised - Pulse 2.0
The Week’s 10 Biggest Funding Rounds: Greentech And Biotech See $200M Raises - Crunchbase News
Thermo Fisher Scientific Expands Solubility Center of Excellence - Pharmaceutical Online
Frequently Asked Questions About Serán Bioscience
What is Serán Bioscience's CDMO Signal Score?
Serán Bioscience has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Serán Bioscience for a manufacturing program?
Use the free AI matchmaker to compare Serán Bioscience against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Bend Bioscience
Bend, OR
Spray Dried Dispersion (SDD), Amorphous Solid Dispersion (ASD), Particle Engineering, Oral Solid Dose, Multiparticulates, Modified Release, Small Molecule API
Codis
St. Louis, MO (US HQ); Haverhill, UK (EU operations)
Spray Dried Dispersion (SDD), Amorphous Solid Dispersion (ASD), Particle Engineering, Oral Solid Dose, Finished Dose Manufacturing, Commercial-Scale Spray Drying